Header cover image

Egyptian (CASE/EGX) Healthcare Sector Analysis

UpdatedJul 13, 2025
DataAggregated Company Financials
Companies16
  • 7D1.3%
  • 3M9.1%
  • 1Y61.2%
  • YTD22.5%

GlaxoSmithKlineE is up 7.7%, leading the way for the Healthcare industry, which has gained 1.3%. This takes the industry's 12 month performance to a gain of 61%. Looking forward, earnings are forecast to grow by 31% annually.

Sector Valuation and Performance

Has the Egyptian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 14 Jul 2025ج.م58.7bج.م98.5bج.م4.3b12.1x13.7x0.6x
Wed, 11 Jun 2025ج.م56.8bج.م97.2bج.م4.0b9.9x14.3x0.6x
Fri, 09 May 2025ج.م55.6bج.م88.3bج.م3.9b9.2x14.1x0.6x
Sun, 06 Apr 2025ج.م53.6bج.م88.3bج.م3.9b9.1x13.6x0.6x
Tue, 04 Mar 2025ج.م50.4bج.م79.1bج.م3.7b15.9x13.7x0.6x
Thu, 30 Jan 2025ج.م49.2bج.م78.0bج.م3.4b17.6x14.6x0.6x
Sat, 28 Dec 2024ج.م46.3bج.م77.9bج.م3.4b18.6x13.8x0.6x
Mon, 25 Nov 2024ج.م45.1bج.م76.9bج.م3.2b15.1x14.1x0.6x
Wed, 23 Oct 2024ج.م47.4bج.م69.2bج.م2.9b10.7x16.5x0.7x
Fri, 20 Sep 2024ج.م37.7bج.م69.8bج.م3.0b11.1x12.7x0.5x
Sun, 18 Aug 2024ج.م34.3bج.م68.8bج.م3.1b7.6x11x0.5x
Tue, 16 Jul 2024ج.م34.9bج.م63.7bج.م3.1b7.6x11.4x0.5x
Thu, 13 Jun 2024ج.م33.3bج.م63.5bج.م3.1b7.6x10.7x0.5x
Sat, 11 May 2024ج.م32.6bج.م58.0bج.م2.5b11.2x13.3x0.6x
Mon, 08 Apr 2024ج.م36.6bج.م57.6bج.م2.9b8.9x12.8x0.6x
Wed, 06 Mar 2024ج.م39.5bج.م56.4bج.م3.0b10.5x13x0.7x
Fri, 02 Feb 2024ج.م34.1bج.م52.6bج.م3.0b10.5x11.4x0.6x
Sun, 31 Dec 2023ج.م31.6bج.م49.4bج.م2.7b8.1x11.8x0.6x
Tue, 28 Nov 2023ج.م32.3bج.م46.9bج.م2.8b11.2x11.7x0.7x
Thu, 26 Oct 2023ج.م27.5bج.م45.6bج.م2.5b10.6x10.9x0.6x
Sat, 23 Sep 2023ج.م25.6bج.م46.2bج.م2.6b10.3x9.8x0.6x
Mon, 21 Aug 2023ج.م24.7bج.م45.7bج.م2.6b10x9.4x0.5x
Wed, 19 Jul 2023ج.م25.1bج.م42.7bج.م2.6b9.8x9.7x0.6x
Fri, 16 Jun 2023ج.م26.2bج.م43.1bج.م2.7b9.5x9.7x0.6x
Sun, 14 May 2023ج.م25.6bج.م41.6bج.م2.9b8.8x8.9x0.6x
Tue, 11 Apr 2023ج.م25.4bج.م41.6bج.م2.9b8.5x8.8x0.6x
Thu, 09 Mar 2023ج.م26.0bج.م41.0bج.م2.8b8.7x9.2x0.6x
Sat, 04 Feb 2023ج.م27.3bج.م40.4bج.م2.8b10x9.7x0.7x
Mon, 02 Jan 2023ج.م28.2bج.م40.4bج.م2.8b10x10x0.7x
Wed, 30 Nov 2022ج.م25.3bج.م40.0bج.م2.8b8x9x0.6x
Fri, 28 Oct 2022ج.م22.9bج.م40.0bج.م2.8b7.7x8.2x0.6x
Sun, 25 Sep 2022ج.م23.1bج.م40.0bج.م2.8b7.8x8.3x0.6x
Tue, 23 Aug 2022ج.م23.7bج.م39.7bج.م2.7b7.8x8.8x0.6x
Thu, 21 Jul 2022ج.م22.2bج.م39.5bج.م2.6b7x8.5x0.6x
Price to Earnings Ratio

8.5x


Total Market Cap: ج.م22.2bTotal Earnings: ج.م2.6bTotal Revenue: ج.م39.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Egyptian Healthcare Sector Price to Earnings3Y Average 11.5x202320242025
Current Industry PE
  • Investors are optimistic on the Egyptian Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 13.7x which is higher than its 3-year average PE of 11.5x.
  • The industry is trading close to its 3-year average PS ratio of 0.61x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 18% per year over the last three years.
  • Revenues for these companies have grown 36% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Egyptian Healthcare sector?

EG Market0.54%
Healthcare1.34%
Pharma3.65%
Healthcare Services-1.21%
Industry PE
  • Investors are most optimistic about the Healthcare Services industry, which is trading close to its 3-year average PE ratio of 22.7x.
    • Analysts are expecting annual earnings growth of 34.7%, which is lower than the prior year's growth of 114.9% per year.
  • Investors are most pessimistic about the Pharma industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 8.2x.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 35% over the next 5 years.
  • However this is lower than its past earnings growth rate of 115% per year.
  • In contrast, the Pharma industry is expected to see its earnings grow by 27% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
RMDA Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)ج.م4.593.6%
+ج.م240.6m
98.7%PE17.7x
PHAR Egyptian International Pharmaceutical Industriesج.م52.513.1%
+ج.م238.0m
34.6%PE9.6x
BIOC GlaxoSmithKlineEج.م40.215.0%
+ج.م161.2m
37.8%PE13.9x
SIPC Sabaa International Company for Pharmaceutical and Chemical Industryج.م2.4333.5%
+ج.م152.5m
261.1%PS26.7x
MPCI Memphis Pharmaceuticals & Chemical Industriesج.م79.717.6%
+ج.م127.9m
-4.9%PE4.5x

Latest News